WHO urges governments to stop subsidizing life-threatening tobacco crops
On World No Tobacco Day, the World Health Organization (WHO) urges governments to stop subsidizing tobacco farming and support more sustainable crops that could feed millions. “Tobacco is responsible for 8 million deaths a year, yet governments across the world spend millions supporting tobacco farms,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “By choosing to […]
76th World Health Assembly
Union Minister of Health and Family Welfare Dr. Mansukh Mandaviya, delivered the Keynote Address at a Quad Plus Side Event on Tuberculosis(Tb) during the 76th World Health Assembly being held in Geneva. The event witnessed the participation of distinguished delegates from Quad Plus countries, reinforcing the commitment to tackle the global health challenge posed by […]
WHO calls for safe and ethical AI for health
The World Health Organization (WHO) is calling for caution to be exercised in using artificial intelligence (AI) generated large language model tools (LLMs) to protect and promote human well-being, human safety, and autonomy, and preserve public health. LLMs include some of the most rapidly expanding platforms such as ChatGPT, Bard, Bert and many others that […]
WHO congratulates Benin and Mali for eliminating trachoma as a public health problem
WHO has validated Benin and Mali as having eliminated trachoma as a public health problem, making them the fifth and sixth countries in WHO’s African Region to achieve this significant milestone. Countries that previously received WHO validation for trachoma elimination are Ghana (June 2018), Gambia (April 2021), Togo (May 2022) and Malawi (September 2022). “WHO […]
Myocarditis - United Kingdom of Great Britain and Northern Ireland
On 5 April 2023, the National IHR Focal Point for the United Kingdom informed WHO of an increase in severe myocarditis in neonates and infants associated with enterovirus infection in Wales compared with 2021. Between June 2022 and March 2023, 15 neonates and young infants presented with a picture consistent with neonatal sepsis in Wales […]
Roche’s BTK inhibitor fenebrutinib significantly reduced brain lesions in people with relapsing forms of multiple sclerosis
Fenebrutinib is an investigational, potent and highly selective oral Bruton’s tyrosine kinase (BTK) inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis (MS) trials Phase II study met its primary and secondary endpoints by reducing the total number of new gadolinium-enhancing T1 brain lesions and significantly reducing the total number of new […]
Union Minister of Health & Family Welfare, Dr. Mansukh Mandaviya interacts with representatives of Japanese Medical Devices Companies
“The medical devices sector is an essential and integral constituent of India’s healthcare sector. The sector’s contribution became even more prominent as India supported the domestic and global battle against COVID-19 pandemic through large scale production of medical devices & diagnostic kits.” This was stated by Dr Mansukh Mandaviya, Union Minister of Health and Family […]
WHO advises not to use non-sugar sweeteners for weight control in newly released guideline
The World Health Organization (WHO) has released a new guideline on non-sugar sweeteners (NSS), which recommends against the use of NSS to control body weight or reduce the risk of noncommunicable diseases (NCDs). The recommendation is based on the findings of a systematic review of the available evidence which suggests that use of NSS does […]
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world’s population has no or limited access to diagnostics This situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIV New partnership between Roche and the Global Fund supports low- […]
WHO and MPP announce agreement with NIH for COVID-19 health technologies
WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalized a licensing agreement with the United States National Institutes of Health (NIH) for the development of several innovative therapeutics, early-stage vaccines and diagnostic tools for COVID-19. The licenses, which are transparent, global and non-exclusive, will allow manufacturers from around the world […]
